TITLE

The year's new drugs

AUTHOR(S)
Rodman, Morton J.
PUB. DATE
January 1980
SOURCE
RN;Jan80, Vol. 43 Issue 1, p97
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Provides information on several drugs approved by the United States Food and Drug Administration in 1979. Pain relievers; Prompt relief for menstrual symptoms; Antihypertensive diuretic.
ACCESSION #
4875134

 

Related Articles

  • FDA approves Exforge HCT for treatment of hypertension.  // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p59 

    The article reports on the approval given by the U.S. Food and Drug Administration (FDA) to the antihypertensive drug Exforge HCT for patients with moderate-to-severe hypertension.

  • Olmesartan label to warn of sprue-like side effects.  // Reactions Weekly;7/13/2013, Issue 1461, p4 

    The article reports that the labels for the antihypertensive olmesartan medoxomil which are to be updated by the U.S. Food and Durgs Administration (FDA) to warn the risk of sprue-like enteropathy.

  • Two diabetes trials leave Benicar at a crossroads.  // Reactions Weekly;6/19/2010, Issue 1306, p2 

    The article deals with the safety review of the antihypertensive medication, olmesartan, being conducted by the U.S. Food and Drug Administration in June 2010.

  • Fixed combination for hypertension.  // Modern Medicine;Sep95, Vol. 63 Issue 9, p27 

    Reports that the US Food and Drug Administration has approved Amlodipine/benazil HCL capsules, the first class of a new class of fixed combination antihypertensive. Availability; Addition of benazepril.

  • Angiotensin receptor blockers and cancer: safety review.  // WHO Drug Information;2010, Vol. 24 Issue 4, p301 

    The article discusses a 2010 decision which the U.S. Food and Drug Administration made to conduct a review of the class of medications known as angiotensin receptor blockers after a study was published which suggested the medications may be associated with a small increased risk of cancer.

  • Counterirritants--The numbing truth. Goldemberg, Robert L. // DCI;Jan1994, Vol. 154 Issue 1, p48 

    Focuses on the effects of capsaicin. Use of pepper sprays for protection; Therapeutic category of capsaicin; Indications for Zostrix; Mechanism of action; Studies on the topical anaesthetic use of capsaicin; Capsaicin's action on pain sensations; Counterirritants listed in the US Food and Drug...

  • Pentazocine--a nonaddicting analgesic. Bellville, J. Weldon; Bellville, J W // Annals of Internal Medicine;Nov67, Vol. 67 Issue 5, p1114 

    Editorial. Comments on the approval by the U.S. Food and Drug Administration of nonaddicting analgesic pentazocine for clinical use. Background on the drug; Review of literature on nonaddicting analgesics; Recommendations for physicians.

  • Action plan in place to curtail opioid analgesic abuse in US.  // Reactions Weekly;5/7/2011, Issue 1350, p2 

    This article reports on the launch of a programme by the U.S. Food and Drug Administration (FDA) to reduce the risk associated with all extended-release and long-acting opioid analgesics.

  • Painkillers to carry warning labels. Lund, Amy E. // Journal of the American Dental Association (JADA);Dec98, Vol. 129 Issue 12, p1670 

    Reports on a ruling of the United States Food and Drug Administration that mandates painkillers to carry warning labels. Contents of the warning; Effects of combining chronic alcohol ingestion and over-the-counter analgesic use.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics